[Pharmacology-biochemistry and physiopathology of tardive dyskinesia: review of the latest findings and controversies].
Tardive dyskinesia is described as a distinct neurological entity. Its probable etiology, pathophysiology and biochemical pharmacology are reviewed and discussed in the light of the latest findings.
Gómez-Galera
A
A
Departamento de Ciencias Neurológicas, Facultad de Medicina, Universidad de Chile.
D000367:Age Factors; D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism*; D002428:Cebus; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D009132:Muscles / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D051381:Rats
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents
Farmacología-bioquímica y fisiopatología de la disquinesia tardía: revisión de los progresos y controversias.